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Abstract
The Blood-brain barrier (BBB) regulates the entry of compounds between
the blood and the brain, thus plays an important role in brain homeostasis.
Studies indicate in disease states such as Alzheimer’s the BBB integrity is
compromised. The motive of this project is to investigate the sensitivity of the
diffusion-weighted arterial spin labeling (DW-ASL) technique to detect water
exchange. Testing the sensitivity requires a reliable method of opening the
barrier at specific locations of the brain. Here, a unique technology named
focused ultrasound (FUS) has been used to mimic a compromised BBB
environment.
A series of experiments were conducted in a piglet model to determine the
ideal settings for a successful BBB opening. The combination of 2.5 W of power,
0.02 ml/kg of microbubble concentration while saturated O2 levels in the piglet
were controlled revealed the most effective BBB opening without causing
hemorrhage. Although the study was able to show a significant BBB opening in
contrast-enhanced MRI, the DW-ASL images showed no significant difference
between the sonicated and non-sonicated ROIs. However, the average water
exchange rate (

) of 106 min-1 measured in this study corresponds to a

permeability surface area product (

) of 159 ml/100 g/min, which was

comparable to the measurements in the prior study involving humans.
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Chapter 1

1

Introduction

1.1 The Blood-Brain Barrier
By regulating the entry of compounds from the blood into the brain, the
blood-brain barrier (BBB) plays a critical role in brain homeostasis (1). The BBB
consists of a series of endothelial cells (EC) that are linked with tight junctions
(TJ) (Figure 1.1). The luminal membrane of the endothelial layer is covered with
a surface glycocalyx layer (SGL), while the basement membrane (BM) surrounds
the abluminal surface. The BM consists of extracellular matrix (ECM) proteins
such as collagen (type IV), heparin sulfate proteoglycans and fibronectin.
Astrocyte foot processes completely surround the tissue side of the capillary wall,
holding the endothelial cells and pericytes in place (2).

Figure 1.1: The neurovascular unit. Adapted from Fisher, M. 2009 (3).
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The majority of molecules that enter the brain tissue through the BBB are
small (under 400 Da) and lipophilic (4). Molecules cross the BBB by either
paracellular or transcellular pathways. The paracellular pathway refers to
transport through the intercellular spaces between cells, such as TJs, while the
transcellular pathway refers to the movement of substances through the cells
themselves. Transcellular transport consists of both active and passive forms
while the paracellular transport consists of only the passive form (Figure 1.2).
Passive transport requires no energy; however, it is powered by hydrostatic,
electrochemical and osmotic pressure gradients. The four types of passive
transport include diffusion, facilitated diffusion, filtration and osmosis. Large
molecules are said to cross the BBB through the transcellular pathway, while
small molecules cross the BBB via the restricted paracellular pathway namely via
diffusion (2).
Hydrophilic ions (sodium, calcium and bicarbonate) and molecules, such
as glucose and lactate, cannot cross the BBB by ordinary diffusion and must rely
on active transporters (i.e., facilitated diffusion) to enter the brain (1,5). The BBB
encompasses different types of transporters to move compounds from blood to
brain: the glucose transporter (GLUT1) for transport of glucose, large neutral
amino acid transporter (LAT1) for shuttling amino acids, and P-glycoprotein and
organic anion transporters to clear waste products from the brain tissue (5). Na+K+-ATPase pumps, which are situated in the abluminal layer of the BBB,
transport sodium and potassium ions between the blood and brain (5).

3

Figure 1.2: Various methods of molecule transport across the BBB. Adapted from Re, F
et al., 2012 (6)

1.1.1

Transport of Water through the Blood-Brain Barrier
Water extravasates from the vasculature across the endothelium layers

via filtration and diffusion. In the muscle capillary endothelium, water movement
occurs through the slits between the cells via filtration and is 50-fold higher than
water propagation via diffusion (5). However, due to the tight junctions between
the EC in the BBB, water transport takes place via diffusion (Figure 1.3). The
restriction of water movement across the BBB adds to the chemical stability of
the microenvironment in the brain tissue (1). To further regulate water movement,
the EC in the brain have very few endocytotic vesicles regulating transcellular
flux. The addition of a BM and astrocyte foot processes around the endothelium
also adds to the stability of the microenvironment in the central nervous system
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(CNS) by lowering the permeability to water and solutes even when the TJs and
the SGL are damaged by either disease or by therapeutic agents (2).

Figure 1.3: The difference between the muscle capillary endothelium and the
brain capillary endothelium (BBB). The lack of pores and slits in the BBB hinders
bulk flow of water

Water movement across the BBB can also occur by Aquaporin 4 (AQP4),
a water-channel protein that has the ability to transfer water molecules in both
directions (7). AQP4 proteins have been found to be located in astrocyte foot
processes bordering the brain parenchyma and main fluid compartments like
cerebral spinal fluid (CSF) and blood, indicating they are crucial for water
movement in and out of the brain parenchyma (8). Research has also shown that
if AQP4 proteins are removed, astrocytes have a 7-fold reduction in water
permeability (7). It has also been shown using a mouse knockout model that
absence of AQP4 caused water accumulation in the brain in response to
ischemia, hyponatremia (Na+ imbalance) and water poisoning (electrolyte
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imbalance due to over-hydration) (7). Additionally, AQP4 deficiency contributes
to brain abscesses, hydrocephalus and vasogenic edema associated with brain
tumors (8).

1.1.2

Blood-Brain Barrier Dysfunction and its Possible Role in
Neurovascular Disease
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid

beta (Aβ) peptide and hyperphosphorylated tau proteins that form plaques within
the brain. These block proteasome function, inhibit mitochondrial activity and
alter Ca2+ levels, ultimately leading to neuronal loss. In addition, the
accumulation of Aβ peptides and tau proteins create neurofibrillary tangles in the
brain (9). The Aβ peptides while in their soluble form are transported from blood
in to the brain by binding to the receptor for advanced glycation end products
(RAGE), while they are cleared out of the brain by the lipoprotein receptor related
protein - 1 (LRP) and P-glycoprotein, in all cases through the endothelial layer of
the BBB (10–12). Research has also shown that RAGE proteins are up regulated
and P-glycoprotein activity diminished with the ageing process, leading to slower
clearance of Aβ peptides (10).
There is evidence that alterations in BBB permeability along with normal
aging can contribute to AD progression by allowing Aβ peptides access to the
brain (11,13). Inflammatory mediators such as bradykinin, seretonin and
histamine increase both the BBB permeability and vessel diameter contributing to
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a significant leak across the BBB (14) and may do so by altering the structure of
the TJ or the transport mechanisms across the BBB (13).
Evidence of increased BBB permeability in AD patients includes the
discovery of blood proteins, immune globin and albumin, in brain tissue (15).
These proteins typically do not cross an intact BBB and their presence in the
brain tissue suggests a compromised BBB, possibly a consequence of or a
contributor to AD. In addition, a contrast-enhanced computed tomography study
reported delayed washout of contrast agent, suggesting BBB dysfunction,
although the results failed to reach significance (16). The loss of BBB integrity
has also been reported in a transgenic mouse model of AD (17), as indicated by
increased uptake of Texas red-conjugated BSA in the brain of the transgenic AD
mice compared to controls.
BBB permeability can also be imaged by magnetic resonance imaging
(MRI) using the contrast agent, gadolinimum-diethylenetriaminepentaacetic acid
(Gd-DTPA). However, the results of contrast-enhanced MRI studies have not
been consistent. Studies of AD patients and dementia patients with white matter
lesions (WMLs) failed to detect a significant elevation in BBB permeability
(18,19). Conversely, another study investigated the BBB permeability in WMLs in
Binswanger’s disease (a form of vascular dementia) and AD patients in
comparison to normal WMLs in controls by assessing the periventricular
hyperinstensity (PVH) in all groups (20). They reported that the BBB permeability
significantly increased in areas of PVH in Binswanger’s disease and AD in
relation to the controls.
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Detecting subtle changes in the BBB integrity associated with AD may be
difficult with contrast-enhanced imaging methods because of the relatively large
molecular weights of the contrast agents. (Gd-DTPA, Molecular weight = 550
Da). Consequently, BBB permeability must reach a critical level before
extravasation can occur. Since water is a small solute, it has been suggested
that measuring the water exchange rate may be more sensitive to subtle
changes in BBB integrity that occur early in the disease process (21).

1.2 Arterial Spin Labeling
Arterial Spin Labeling (ASL) is an MRI-based technique for measuring
cerebral blood flow (CBF) by using water as a flow tracer (22). Although primarily
a perfusion technique, ASL can also be made sensitive to water exchange
across the BBB (23) which will be described in more detail in Section 1.3. ASL
measures CBF by altering the magnetization of arterial blood water flowing into
the brain, causing a small reduction in the MRI signal. The application of a RF
pulse inverts the net magnetization of the water in the blood. After some time
(transit time) an image is acquired and that image is called a ‘labeled/tagged’
image. The image that is acquired without the inversion of the net magnetization
of blood water is called a ‘control’ image. This perfusion-weighted signal (ASL
signal) can be isolated by subtracting a labeled image from the control image in
which the arterial blood magnetization is at equilibrium (24). The technique has
been validated by comparing the perfusion measurements to established
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perfusion techniques such as perfusion computed tomography (25), positron
emission tomography (PET) (26), and single-photon emission computed
tomography (SPECT) (27).
The two ways of tagging arterial blood water are pulsed and continuous
ASL. Pulsed ASL (PASL) tags water when a single RF pulse is applied to invert
the magnetization of a slab of arterial blood (28). Continuous ASL (CASL) tags
water with a continuous flow-dependent adiabatic inversion of arterial blood
magnetization, which is described in detail in the next section since it was the
technique used in the experiments outlined in chapter 2.

1.2.1

Continuous Arterial Spin Labeling
With CASL, a constant low-power radiofrequency (RF) pulse is applied in

the presence of a weak magnetic field gradient (22,29) to cause moving
magnetic spins in arterial blood to experience a variation in resonance frequency,
analogous to a classic adiabatic full passage (AFP) (Figure 1.4 a). For the spins
to be successfully inverted under these circumstances, the ‘adiabatic condition’
must be met:
(1.1)

⁄

Where,
relaxation time,

is the longitudinal relaxation time,
is the RF magnetic field strength,

is the transverse

is the gradient strength,
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is the linear velocity of the inflowing arterial spins, and

is the gyromagnetic

ratio of protons.

Figure 1.4: The white lines depict the imaging slice. (a) Continuous adiabatic inversion
(red line) is applied proximally to the imaging slice. (b) An off - resonance pulse (red line)
is applied distally to the imaging slice to correct for magnetization transfer (MT) effects.
(c) Double inversion of arterial spins using amplitude- modulated CASL for multislice ASL
imaging.

If the adiabatic condition is satisfied, the arterial magnetization for the
labeled

and control (

) conditions are governed by:
(1.2)

(1.3)
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where λ is the blood/tissue partition coefficient of water (0.9 g/ml), R1a is the
longitudinal relaxation rate of blood and

is the equilibrium magnetization of

tissue. As per the above equation, the blood magnetization is a function of
equilibrium tissue magnetization because the water concentrations in the arterial
space and tissue space are in equilibrium. The exponential term accounts for the
arterial transit time,
magnetization

, which is the delay between the inversion of the arterial

(labeling)

and

its

arrival

at

the

imaging

slice

(arterial

compartment). Then the ASL signal in the arterial compartment is given by:

(1.4)

{

where,

is the duration of the labeling period and

is the labeling efficiency

which accounts for the fraction of spins that were inverted. A number of factors
such as RF field, relaxation effects and variations in blood velocities reduce the
labeling efficiency (30)
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A potential source of error with CASL is the labeling RF field causes offresonance saturation in the imaging slice due to magnetization transfer (MT)
effects. The perturbation of tissue macromolecules in the imaging slice causes
signal changes that are significantly larger than the signal due to the inflow of
labeled blood and, therefore, must be corrected for. A simpler way of avoiding
MT effects is to apply an off-resonance pulse distally to the imaging slice during
the acquisition of the control image (Figure 1.4 b). This off-resonance pulse
causes the same MT effect as the labeling pulse but has no effect on the arterial
spins. The disadvantage is that only one image can be acquired at a time
because MT effects are managed at an equidistant from the label and control
planes. The change in magnetization due to the continuous labeling of arterial
blood is given by:

(1.5)

{

where,

{

[

]

}

is the tissue relaxation in the presence of a off - resonance RF pulse

and F is the cerebral blood flow (mL/100 g/min). If the labeling period is ideally
long, the delivery of labeled blood and the rapid loss of that label by relaxation
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will achieve a steady state. However, the ASL signal is generally only 1% of the
signal because of the rapid relaxation of the labeled water.
By applying an amplitude-modulated off-resonance RF pulse, it is possible
to acquire multiple slices with the reduction of MT effects (31). During the
acquisition of the control images, a constant RF pulse is applied similar to the
tagged image, but the amplitude of the RF pulse is modulated to cause the
flowing spins to be inverted twice, yielding a zero net effect (Figure 1.4 c). The
average power and the center frequency of the amplitude-modulated control
image slice is identical to the average power and frequency of the tagged slice,
therefore off resonance effects are identical to the tagged image (31,32).
However, the labeling efficiency of amplitude modulated CASL is considerably
less than standard CASL, typically around 68% due to imperfections in the
amplitude-modulated control pulse (double inversion) (33). An alternative
approach of avoiding MT effects is to use a separate RF coil placed on the neck
to invert the arterial magnetization; however, this requires specialized equipment
– a labeling coil and an additional RF channel that is typically not supplied with a
clinical MRI system.
Pseudo-continuous ASL (pCASL) was developed to overcome the poor
labeling efficiency of amplitude-modulated CASL (33,34). Continuous labeling is
achieved by applying a train of closely spaced RF pulses that are applied with a
pulsed gradient field. These pulses are able to achieve a flow-driven adiabatic
inversion. There are a number of advantages in employing pCASL: (1) MT
effects are corrected across all slices since the control and label pulses are
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applied at the same location. (2) It does not require a specialized RF coil for
labeling to avoid MT effects. (3) It has the ability to obtain a higher labeling
efficiency (81% compared to 68% in amplitude- modulated ASL) (34).

1.3 Quantification Issues in ASL
The ASL signal is not only influenced by CBF, but can also be affected by
the time it takes magnetically labeled water to reach the region of interest in the
brain, as indicated by equations 1.4 and 1.5. The total transit time is generally
given by two transit times. The first is the time it takes magnetically labeled
arterial blood to travel from the labeling site to the arterioles in a given MRI voxel,
which is labeled

in Figure 1.5. The longer transit time is the time it takes

labeled water to reach the capillary bed, where it can diffuse across the BBB into
tissue, is labeled

.

One approach for estimating the tissue transit time is by flow-encoding
arterial spin tagging (FEAST). According to this technique two ASL scans are
acquired: one with (ex: b = 10s/mm2) and one without a flow-spoiling magnetic
gradient. The b-value describes the strength of the diffusion gradient. The
application of this gradient enables the signal from the arterial and tissue
compartments to be separated. The tissue transit time ( ) is calculated by the
following equation:

[

]⁄

(1.6)
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Where

is the post labeling delay (described later), while ∆

is the ratio

of ASL signals with and without the diffusion gradients (35).
[
[

A typical

]
]

(1.7)

in humans measured by FEAST ranges from 1150 to 1550 ms from

the bottom to the top slice.

Figure 1.5: The two-compartment model for CASL consisting of the arterial and
tissue compartments. The time it takes labeled blood to reach the arterial
compartment is the arterial transit time ( ), and the time it takes for labeled blood to
reach the tissue compartment is the tissue transit time ( ).
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An alternative approach for reducing the sensitivity of the

signal to

is to add a post labeling delay (PLD) between the end of the labeling period and
the beginning of the image acquisition (30). If the PLD is too short, a significant
fraction of the labeled water remains in the feeding arterial compartment and the
signal is sensitive to

. If the PLD is optimal, then all of the labeled water will

reach the tissue compartment, where exchange occurs between the capillary and
the surrounding tissue. However, one must be careful in not employing an
extremely long PLD which will result is a substantial loss in signal-to-noise ratio
(SNR) (36).
Although the human blood volume is only 5% of the entire brain volume,
the ASL signal is heavily weighted to the arterial side of the vascular system
because of the rapid

relaxation of the magnetic label (30). Consequently, the

arterial signal in ASL can be much greater than the tissue signal, leading to ‘hot
spots’ in the perfusion images (i.e. areas of artificially high CBF values). This
effect can be accounted for by using a sufficiently long PLD to allow all of the
labeled water to reach the tissue bed, or by applying diffusion gradients to
suppress the vascular signal (36).

1.4 Assessing Water Exchange Across the BBB by ASL
Although ASL is a perfusion technique, it can be sensitized to water
exchange across the BBB by exploiting differences in the magnetic properties of
labeled water in blood and tissue (23,37,38). The fractions of labeled water in the
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blood and tissue will depend on the rate of exchange across the BBB, which is
characterized by the permeability surface area product (PS) of water (Figure 1.6).
There are primarily two approaches to accessing water exchange between the
two compartments: (1) using the difference in

relaxation between blood and

tissue and (2) separation of signals from the two compartments by applying
diffusion gradients to suppress the faster moving magnetic spin in blood.

Figure 1.6: Capillary – Tissue Exchange Model. The BBB separates the two
compartments.

and

represent the magnetization in the capillary and

brain tissue spaces. The capillary blood volume ( ), the longitudinal relaxation of
blood (

), the tissue blood volume ( ) and the longitudinal relaxation of tissue (

)

are also shown for the respective compartments.

The first application in humans of the

relaxation approach was by

Parkes and Tofts who proposed that the rate constant characterizing water
exchange could be determined by acquiring ASL data at multiple post-labeling
delays, and including water exchange as an additional fitting parameter in the
kinetic analysis (37). Parkes and Tofts as well as Zhou et al., concluded that the
capillary permeability is an important factor that must be accounted for in
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perfusion quantification (37,38). Further improvements to this approach include
the development of techniques that account for transit time effects (39) and a
two-stage method that attempts to measure the PS product of water directly (40).
However, the study by Carr et al., questioned the precision of this approach
because of the similarity in

values between blood and brain tissue (41). The

precision can be enhanced by using imaging methods that are also sensitive to
differences in

and

values between blood and tissue (42,43). Recently,

Gregori et al. proposed a multi-echo, single-shot 3D technique to generate
simultaneous images of cerebral perfusion and water-exchange (44).
The application of diffusion gradients is the second method of measuring
water exchange (45–47). This approach uses weak diffusion gradients to
differentiate the signal contributions from slowly diffusing water in the
extravascular space and rapidly moving water in blood. Wang et al. adapted this
approach to human applications using a relatively long PLD to allow most of the
labeled spins to reach the microvasculature. The study concluded that depending
on the PLD and the strength of the diffusion gradient the ASL techniques can be
made sensitive to either the arterial, capillary or tissue compartments (46).
Additionally, bipolar gradients with strength around 50 s/mm2 were found to be
sufficient

to

eliminate

signal

contributions from

labeled

water

in

the

microvasculature. The most recent study incorporated pCASL to increase the
SNR and FEAST imaging (35) to measure the arterial transit time (47). This
approach will be discussed in more detail below as it forms the basis of the
approach used in this thesis.
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Regardless of the method used to separate the signal contributions from
blood and tissue, quantification of the rate of water exchange is done by using a
kinetic model that divides the total brain concentration of labeled water into two
subspaces: capillary and brain tissue (Figure 1.6). The perfusion-weighted signal
is then defined by the sum of labeled water in each compartment (23) :
(1.8)
where

represent the capillary and brain tissue concentrations of

labeled water for an idealized impulse input of unit concentration. The symbol 
refers to the convolution operator and originates by treating the uptake of labeled
water in tissue as a linear, time-invariant system. The definition of

accounts

for loss of labeled water due to the extraction of water into the tissue and
relaxation.
(1.9)

(1.10)
Where

is the time it takes for the labeled water to travel from one end of the

capillary to the other end,
(mL/100mg) and

,

is the capillary blood volume

is the longitudinal relaxation rate of blood. Similarly, the

amount of labeled water in the tissue space is given by:
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(1.11)

(1.12)

where,

(

)

and

(

)

.

(1.13)
These equations show that the parameters

,

and E depend on water

exchange between capillaries to tissue. The rate constant defining this exchange
rate, denoted

, is given by (23)
(1.14)

where,

is the capillary permeability surface-area product of water

(mL/100g/min) .
Because
measuring

is also dependent on the arterial input function, accurately
requires measuring

. As mentioned earlier, the two-stage

approach proposed by St. Lawrence et al., acquired ASL images with different
diffusion gradient strengths and different PLDs (47). First, arterial transit time (
is measured by the FEAST approach using a PLD delay long enough to allow all
labeled water to reach the arterial compartment (800 ms) and a diffusion gradient
strong enough to crush the magnetization of labeled water in the arteries (b = 10
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s/mm2). The acquisition was repeated, but with the PLD increased to 1500 ms to
allow all labeled water to reach the tissue compartment and the strength of the
diffusion gradient increased to 50 s/mm2 to crush the magnetization of slowmoving labeled water in capillaries. From here onwards, this imaging technique
will be referred as the diffusion-weighted ASL (DW-ASL).
When the PLD is greater than the tissue transit time, the ASL signal in the
capillary space

and in the tissue space

are given by

(

[

(

(

where

(1.15)

)

)

(1.16)

)]

is the longitudinal relaxation in the brain tissue.
The assumption with DW-ASL is that

and

can be

separated by the application of bipolar gradients because labeled water is
moving faster in capillaries than static tissue. Therefore, the ASL signal collected
at the two diffusion gradients (b) can be written simply as
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(1.17)

where

and

are the fast (capillary) and slow (tissue) components of the

ASL signal, and

+

(t) = 1. The corresponding pseudo diffusion

coefficients for the capillary and tissue labeled water are referred as

and

.
(1.18)

(1.19)

where

and

are written as functions of time because their values will change

depending on the PLD. As the labeled water diffuses from the capillaries in to the
tissue,

decreases in the presence of a long PLD. Assuming the capillary

contribution is suppressed when the diffusion gradient is applied (
and

), then

can be written as,
(1.20)

(1.21)
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The fraction of labeled water in the tissue and capillary spaces, as defined by
and

, will depend on

and

.

The latter is determined separately by the

FEAST data.
Applying this technique on healthy human subjects (47), a PLD of 1500
ms was chosen to allow all labeled water to reach the capillary space as
confirmed by average

of 1.49 s for whole-brain grey matter. The average

value was 110 min-1 for grey matter and 126 min-1 for white matter. Using an
assumed value for the capillary blood volume ( ),

ranged between 165 to

220 mL/100g/min, in reasonable agreement with values measured by positron
emission tomography.
The main challenge to measuring

is achieving an acceptable degree of

precision due to the inherently poor SNR of ASL. The rapid

relaxation of

labeled blood is the primary reason for the poor sensitivity. To overcome this
issue, investigators have used relatively long acquisition periods (~10 min),
employed a echo-planar imaging (EPI) or spiral imaging techniques to reduce
motion artifacts, used higher field strengths to enhance relaxation time
differences between blood and tissue, and used phased array RF coils to
improve sensitivity.
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1.5 Opening the Blood-Brain Barrier
An established approach for opening the BBB is to inject mannitol
intracarotidly. The rapid elevation in plasma osmolality causes the endothelial
cells to shrink, leading to openings in the TJs (Figure 1.7). Increased BBB
permeability following carotid infusion of mannitol (25%) has been shown in a
number of animal species including rats and rabbits (48,49). However, the results
have not been consistent, with variations in magnitude and distribution of BBB
disruption reported (50).

Figure 1.7: (A) Before and (B) administrating an osmotic agent. Injection of The
hyperosmolar osmotic reagents leads to shrinking of the endothelial cells and
subsequently enlarges the pore size by opening the TJs. Adapted from Rebeles, F et
al., 2006 (52)

In swine, the effects of mannitol are even less conclusive. Anwar et al.,
reported no increase in regional BBB permeability in newborn pigs. Marchi et al.,
were able to open the BBB in adult pigs, as demonstrated by contrast-enhanced
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MRI and Evans Blue staining. However, only one third of the experiments
showed noticeable disruptions and these were characterized by a patchy
distribution of leakage spots (51). Considering that piglets were selected for
these experiments (see Section 1.8), a more consistent method of opening the
BBB at specific locations in the brain is required.

1.6 Introduction to Focused Ultrasound
Focused ultrasound (FUS) was initially proposed in the 1940’s as a
method of producing focal heating with minimal effect on surrounding tissue (53).
It is now used to deliver thermal therapy to a number of cancers including brain
(54), breast (55,56), bone (57,58), and prostrate (59–61). Bakey et al., first
proposed the concept of using high-intensity FUS to open the BBB in 1956, and
there were a few studies reported over the next few decades. However, the
feasibility of the approach improved dramatically with the advent of low-frequency
pulsed FUS applied in the presence of encapsulated gas-filled microbubbles
(MBs) (diameter ≤ 8 μm) (62). Blood-brain barrier disruptions (BBBDs) are
caused by the interactions between sonicated MBs and the layer of endothelium
lining the BBB. At lower pressures, tissue damage and skull heating is avoided
and BBBDs are transient, typically closing within 24-hours (63). The two primary
mechanisms that contribute to BBBD are radiation pressure and cavitation.
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1.6.1

Mechanisms for Blood-Brain Barrier Disruption: Acoustic
Cavitation and Radiation Pressure
Acoustic cavitation refers to the phenomenon of formation and collapse of

gaseous cavities due to the interaction with an ultrasound wave. That is, MBs in
the blood stream will contract and expand with the compression and rarefaction
points in the ultrasound wave. The severity of the interaction depends on the
frequency, pressure amplitude and duration of the sonication, as well as the size
and volume of the gas bubbles (64).
Shear stress or radiation force (Figure 1.8) plays a significant role in
advocating stable cavitation to disrupt the BBB when the acoustical pressure
limits are low (65). Inertial cavitation will occur if the ultrasound intensity (or high
acoustical pressure) exceeds a threshold pressure. This threshold is typically
around 0.45 MPa when ultrasound is delivered transcranially (65,66). Rapid
growth and collapsing of MBs can induce temperature elevations, high velocity
jets and shear stress, all leading to tissue damage (62,64). Therefore it is best to
avoid reaching high acoustical pressures as they lead to permanent BBBD.

Figure 1.8: Possible mechanisms for BBBD via FUS and MBs: TJ separation by
radiation force, bubble oscillation or by acoustic streaming. Adapted from
Vykhodtseva, N et al., 2008 (62)
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1.6.2

The Role of Microbubbles in Focused Ultrasound
The injection of MBs prior to sonication for the purpose of generating

bubbles in the brain blood vessels to aid BBBD was first suggested in 2001 (63).
Hynynen et al., injected an IV bolus of Optison (GE Healthcare, Milwaukee, WI)
and demonstrated that the BBBD they witnessed had no neuronal damage, was
reversible, and the acoustic pressure was two orders of magnitude lower than
what was typically needed for tissue ablation (63,67). The BBBD is correlated to
the interaction between the ultrasound field and the MBs. MBs have been able to
reduce the acoustic energy requirement and avoid overheating of the skull during
FUS BBBD (68).
There are 3 brands of commercially available MBs in the world market
namely Definity (Lantheus Medical Imaging, MA, USA), Sonovue (Bracco
Diagnostics Inc, Milan, Italy) and Optison (GE Healthcare, WI, USA). However,
only Definity MBs are available for use in North America, they have been used in
this study. All 3 types of MBs are micron-sized and filled with a perfluorocarbon
gas, surrounded by either an albumin or a phospholipid layer. Definity MBs are
filled with Octafluoropropane (OFP, C3F8) covered by a phospholipid shell and
are between the diameters of 1.1-3.3μm with a half-life of 1.3min (68,69). The
diameter of the MBs is a critical factor in the amount of BBBD achieved as well
as in the reversibility of the disruption.
Additional factors such as resonance frequency, pressure threshold for
cavitation, bubble expansion ratio, lifetime of stable cavitation and duration of
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opening are all determined by the diameter of the MB (65). Larger bubbles exert
a stronger shear stress on the capillary wall in comparison to smaller bubbles.
On the other hand, the acoustical pressure demand by a small bubble would be
much larger to reach the same bubble expansion achieved by a larger bubble
(70). Additionally, previous studies have also found that the pressure threshold
for BBBD with inertial cavitation falls between 0.30 - 0.45 MPa for MBs in the 1-2µm range while BBBD with stable cavitation using MB sized between 4-5 and 6-8
µm holds a pressure threshold of 0.15 - 0.30 MPa (66). However, the expansion
of a MB is inversely proportional to its diameter; therefore, it is beneficial to use
smaller MBs (1-2μm) if one requires the BBB to recover faster. It is also known
that MBs smaller than 2.5 μm are not capable of opening the BBB in sites away
from the larger vessels due to bubble fragmentation, even before the MBs have
reached the microvasculature which feeds the endothelium (65).
In terms of MB dose the FUS community is divided; one study revealed
that MB dose had no effect on the volume of BBBD (71), while several studies
have stated that the volume of BBBD increased as they increased the MB dose
(72–74). In summary, the resonance frequency, shear stress, permeability, and
BBB recovery time decrease with decreasing MB size, while the pressure
threshold and the expansion ratio increases.
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1.6.3

The Effect of Acoustic Parameters of Ultrasound
The effect of various acoustic parameters on the volume of observed

BBBD have been extensively studied. The volume of BBBD and BBB recovery
time both increased with increasing pressure of the incoming ultrasound wave.
However, one study that used a 1.08 MHz transducer with sonication times of
~300 s witnessed that BBBD was reduced at pressures > 0.5 MPa. They
concluded that successful delivery of agents across the BBB increases only
when the pressure is less than the threshold for generating a lesion (~0.45 MPa)
(75). The same team also experimented on the effect of sonication time on the
amount of BBBD created and noticed that the BBBD effects plateaued after
reaching a sonication time of 600 s (75). One must also note that increased
sonication times result in increased degree of damage to the tissues.
As the frequency of the ultrasound transducer is increased the pressure
threshold to generate BBBD increases. When the frequency of the transducer
matches the resonance frequency of the MBs, the transfer of energy from the
ultrasound wave to the MB occurs effectively to cause a BBBD (65).
The relationship between the pressure threshold and frequency for
effective BBBD without causing lesions is approximately equal to a Mechanical
Index) MI of 0.46 (71)
(1.22)
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The relationship between the pulse length and the BBBD has also been
widely studied. The BBBD is reduced when the pulse lengths are shortened (<1
ms), however increment of closely timed short pulses enhances the BBBD
(61,66). Longer pulses created more BBBD (63,77) and it has been suggested
this could be possibly due to radiation pressure caused on the endothelium (22).

1.6.4

Challenges to Disrupting the Blood-Brain Barrier by Focused
Ultrasound
The skull is the major obstacle in delivering ultrasound waves to the brain.

Because the skull bone is heterogeneous and is unevenly shaped, almost 90% of
the propagating FUS wave is lost (64). The speed of sound in the skull is
~2900m/s, twice that of water and because the thickness is varied the speed of
sound differs at different locations (78). The relatively high speed of sound
coupled with variable thicknesses distorts wave propagation and destroys the
focus of the ultrasound beam. Additionally, beam refraction can occur if the
ultrasound beam causes a non-normal incidence to the skull. Due to the above
challenges early research in the field was performed with a craniotomy to deliver
ultrasound to the brain.
Furthermore, because the acoustic impedance of bone is much different
from water or soft tissue there are energy losses at the bone-tissue interface. At
low frequencies reflection is the cause for majority of energy losses. However, at
high frequencies scattering and absorption dominate. FUS delivery through the
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skull over the frequency of 1 MHz is next to impossible unless performed through
an acoustic window or by transcranial Doppler ultrasound. Acoustic windows are
an area of the brain where the skull bone has not yet developed. Therefore, in
newborns ultrasound scans can be performed through the anterior fontanelle and
in adults through the temporal or the suboccipital windows (78).
Lastly, the reflective nature of the skull bone can create standing waves
during long sonication times. Standing waves create unanticipated hot spots
especially in healthy tissue and are a major concern in therapeutic FUS due to
the causation of hemorrhage. The amount of observed standing waves increased
as the frequency of the transducer decreased (79). Although small aperture
arrays create significant amounts of standing waves, large aperture arrays (up to
1372 elements) in a tightly focused transducer (lower f-number) with a reduced
duty cycle in pulsed mode will reduce skull heating, allow beam focusing and
lessen standing waves (80).
Recent studies have shown that the life of the MBs while circulating in the
microvessels decreased 3-times faster when Isoflurane is used with oxygen as
the carrier gas instead of medical air (81). Another study states that Definity MBs
act as an osmotic agent swelling up bringing in oxygen and nitrogen in to the
MBs. This is because Definity MBs are filled with OFP, which has low plasma
solubility. However, when MBs are in close proximity of the pulmonary system,
OFP in the MBs equilibrate with the gas in the alveolar space, OFP is lost and
exhaled even before sonication has been completed (82). Moreover, as the OFP
gas content in the MB decreases through time, the surface tension and the
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ultrasound peak pressure increases. As the FUS wave propagates through the
MB, the vapor pressure of OFP goes over the threshold converting OFP gas to
liquid (81).
Although the loss of OFP in the alveolar space diminished the MB
survival, the addition of the OFP can prolong the MB survival. Using medical air
as a carrier gas in conjunction with Isoflurane during the sonication process can
improve the MB survival.

1.7 Porcine Studies to Date
So far there have been three groups that have investigated ultrasound
induced BBBD in a swine brain. However, out of these studies only one has
been conducted by using focused ultrasound while two studies have been under
unfocused ultrasound, thus our study would contribute to determining FUS
parameters for a swine model.
One study involved 24 adult pigs anesthetized under Isoflurane whom
were sonicated transcranially through the temporal bone with a 1 MHz unfocused
transducer, with a pulse duration of 2 ms and a pulse repetition frequency (PRF)
of 100 Hz. The intensity of the transducer was 2 W/cm 2 and the duty cycle was
maintained at 20%. The MBs used in this study were lipid encapsulated (ImaRx
Therapeutics, AZ, USA) and perfluorocarbon-exposed sonicated dextrose
albumin (PESDA) that were prepared on site. The BBBD was short lived, up until
30 min and after 120 min they were not able to detect a significant uptake of
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evans blue (EB). There was also no significant uptake of Gd-DTPA after 120 min.
The decrease in peak negative pressure by 10-times was blamed on beam
attenuation due to sonication through an intact pig skill. Additionally, the BBBD
achieved in this study was short-lived, while an insignificant uptake of EB was
also observed (83).
A group in Taiwan sonicated 10 adult pigs with a 28 kHz (low-frequency)
commercially available system (K-Sonic Inc., Taiwan) that were anesthetized
under chlorohydrate (30 mg/kg).

The sonication parameters include a burst

length of 30 ms (group1, n=3) or 100 ms (group 2, n=3), PRF of 1 Hz and a
sonication time of 5 min. A craniotomy was conducted to position the 28 kHz
ultrasound probe and MBs used were Sonovue (0.05 mL/kg). Prussian blue
stained sections confirmed that the 30 ms bursts successfully disrupted the BBB
in two out of three of the animals while the disrupted regions itself were larger in
all three of the animals treated with 100 ms bursts. However, the

images of

the group 2 animals indicated hemorrhage and H&E staining also confirmed by
showing large scale erythrocyte extravasation (84).
The only study on pigs to date using a focused ultrasound transducer
sonicating at a frequency of 0.4 MHz (Imasonics, France) with the assistance of
a neuronavigation system (Stryker, Germany) found that a negative pressure of
0.43 MPa resulted in consistent BBBD. The FUS parameters were a burst length
of 10 ms, a PRF of 1 Hz for a sonication time of 30 s. However, this study was
also conducted after a craniotomy and the use of a 3x3 grid pattern to perform
the sonication points fed in to a successful BBB opening (85).
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1.8 Objectives, Rationale and Overview of the Project
The overall goal of the project was to determine if a novel ASL technique
is sensitive to changes in the BBB. Since pCASL images suffer from poor spatial
resolution (3.75 x 3.75 x 8 mm3), it is important for this study to choose an animal
model with a reasonably large brain such that it could be imaged in a 3.0 T MRI
scanner, which is the same field strength used in previous human studies
(46,47). Therefore, piglets were chosen for this study. To test the sensitivity of
the technique, a reliable method of opening the BBB at known locations was
required. For this purpose FUS was selected over osmotic agents such as
mannitol.
Although FUS-assisted BBBD has been explored, the effectiveness of the
disruption depends on multiple factors including the animal model, ultrasound
power, sonication time, MB concentration, incidence angle of the ultrasound
wave and gas exchange effects due to the selected anesthesia protocol.
Therefore, as a secondary objective of this study, preliminary experiments were
conducted to select the optimal FUS parameters to open the BBB in a piglet.
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Chapter 2

2

Materials and Methods

2.1 Animal Preparation
This research study was approved by the Animal Use Subcommittee of
the Canadian Council of Animal Care at Western University. Experiments were
performed on Duroc piglets (1-5 days old, mean weight of 2.13 ± 0.28 kg)
obtained from a local supplier on the morning of the experiments. Each piglet
was anesthetized with Isoflurane (4-5%) during preparatory surgery and
stabilized after with 2-3% Isoflurane. The animal was tracheotomized and
mechanically ventilated on an oxygen and medical air mixture. A 22 gauge
catheter, was placed in a ear vein to infuse Gd-DTPA, MBs, and EB. Once the
animal was ventilated, a femoral artery line was surgically placed to monitor
mean arterial pressure (MAP) and to extract blood samples to measure arterial
CO2 and O2 tensions (PaCO2 and PO2, respectively) as well as the glucose
concentration. Heart rate (HR), pH, and rectal temperature were also monitored.
The temperature was maintained between 37.5°C and 38.5°C by a recirculating
water heating pad.
Following the surgical procedure, the piglet’s head was shaved and placed
on a custom-built platform with an opening to expose the head to the focused
ultrasound wave. To avoid the formation of standing waves and reduce energy
loss due to refraction, the head was oriented such that the incidence angle of the
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FUS wave was normal to the skull. The head was secured to avoid any head
movements during the experiment.

2.2 Experimental Procedure
2.2.1

Sonication Protocol
Sonication was performed using an MRI-compatible, image-guided

focused ultrasound system with a three-axis positioning system, which is capable
of delivering focused ultrasound to precise locations in soft tissue (FUS
instruments Inc., Toronto, ON) (Figure 2.1). The transducer is spherically focused
and has a diameter of 7 cm (f-number = 0.8). It is able to target with a 0.1 mm
precision and can sonicate up to a maximum power of 9 W (1.88 MPa).

Figure 2.21: Left: The monitor that displays the GUI. Middle: The FUS system that
is filled with degassed water. Right: The electronics cart consisting of the controls
and power supply. (Images from http://www.fusinstruments.com)
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The FUS system was placed on the bed of a 3T Biograph mMR scanner
(Siemens Healthcare, Erlangen, Germany). The tank housing the transducer was
filled with degassed water. The FUS system was co-registered to the MRI with
the assistance of a calibration plate supplied with the FUS system. The left /
right, anterior / posterior and head / foot positioning of the focal spot in the
calibration plate was entered on the FUS system as the center of the transducer.

Figure 2.22: Locations of the axial T1-weighted images, which were defined using
landmarks identified in the sagittal images.

After the application of ultrasound gel to the piglet’s head, the piglet was
placed supine on an experiment plate with an acoustic window. The position of
the brain was defined by acquiring a coronal localizer image using a 4-channel
flex coil wrapped over the piglet’s head. Next, a set of sagittal

-weighted
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images (TR/TE: 500/12 ms, matrix size: 128 X 128, FOV: 140 mm, 15 slices of
thickness 2.5 mm and spacing of 0.25 mm) were acquired to select the axial slice
position for sonication. A set of axial

-weighted images was acquired (TR/TE:

500/12 ms, matrix size: 128 X 128, FOV: 128 mm, 23 slices of thickness 2.5 mm
and spacing of 0.25 mm). The position of these images were chosen based on
landmarks in the sagittal images and arranged such that the location of the most
distal image touched the base of the brain and the center slice coincided with a
bright blood vessel (Figure 2.2). Sonication was performed in two consecutive
slices near the centre where the brain was the largest.
The transducer was operated at a frequency of 0.563 MHz and at a pulse
rate of 1 Hz with 10 ms burst length for 1% duty cycle for each sonication. Six
sonications were performed in a grid pattern in the right hemisphere at 2 mm
spacings. The pattern was repeated on a consecutive slice 2.5 mm apart, for a
total of 12 sonications (Figure 2.3).

Figure 2.3: Schematic diagram of the FUS set up during sonication. Right:
image showing the location of six targeted points.

-weighted MR
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A single bolus of Definity MBs (Lantheus Medical Imaging, MA, USA) at a
dose of 0.02 mL/kg was intravenously injected through the ear vein at the start of
each sonication. Each sonication was 120 s, and partial pressure of oxygen
(PaO2) was maintained between 70-90 mmHg to prolong the MB survival in the
vasculature. The total sonication time, including a minute delay between
successive sonications, was 36 minutes. PaO2 was increased to greater than
100 mmHg once the sonication was completed.

2.2.2

Permeability Imaging Protocol
After sonication, the piglet was lifted off the FUS system, while remaining

strapped to the platform, and the FUS system was removed from the scanner.
The piglet was placed in a 15-channel, 154-mm diameter transmit/receive coil
supplied by the manufacturer. The platform was carefully leveled to replicate the
position of the head during sonication. A set of sagittal

-weighted images with

the same imaging parameters as before was acquired to landmark the location of
the sonicated region. The location was confirmed by acquiring a set of axial

-

weighted images (named the pre Gd-DTPA images) using the same imaging
parameters used with the flex coil.
A schematic diagram of the DW-ASL sequence used in this study is
shown in Figure 2.4. The sequence is a combination of pCASL and twicerefocused spin-echo diffusion echo-planar imaging. The pCASL sequence
consisted of a train of 1600 Hanning-shaped RF pulses with a pulse duration of
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500 μs, a spacing of 920 μs, peak B1 of 5.3 μT, and an average B1 of 1.8 μT. The
RF pulses were implemented in conjunction with a slice selective gradient of 6.0
mT/m for a total labeling time of 1.5 s. The labeling plane was placed 4 cm below
the center of the imaging volume. This distance was selected because the
carotid arteries are straight at this location, as confirmed by MR angiograms
acquired in preliminary experiments. The DW-ASL sequence includes a PLD in
which two nonselective inversion pulses are applied to suppress the static
magnetization. Diffusion gradients with b-values of 0 and 50 s/mm2 were applied
along the slice direction.

Figure 2.4: The DW-ASL sequence is a modification of the standard pCASL technique. DWASL consists of pCASL with a twice-refocused spin-echo diffusion imaging sequence. Adapted
from St. Lawrence et al., (47)
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The ASL images were positioned such that the middle slice was centred
on the sonicated region as determined from the axial

-weighted images. Both

the FEAST and DW-ASL images were acquired with the following imaging
parameters: FOV = 240 mm, matrix = 64 x 64, BW = 2790 Hz/pixel, 7/8 partial kspace, GRAPPA = 2, slice thickness = 8 mm, inter-slice gap = 1.28 mm, 7 slices,
TE = 48 ms, and TR = 3500 ms. FEAST data were acquired with b values of 0
and 10 s/mm2, PLD = 500 ms, and 96 acquisitions. DW-ASL images were
acquired with b values of 0 and 50 s/mm 2 (96 and 192 acquisitions, respectively)
and a PLD = 1000 ms.
Following the ASL imaging,

-weighted images were acquired to detect

any hemorrhaging caused by the sonication (TR = 90 ms, Flip Angle = 20°, first
TE = 4.92 s, echo separation = 5.17 s, number of echoes = 10, BW = 260
Hz/pixel, matrix size = 128 X 128, and FOV = 128 mm). One 5 mm thick slice
was acquired centered on the sonicated region. Finally, Gd-DTPA was injected
intravenously (0.2 mL/kg; Magnevist, Bayer Healthcare Pharmaceuticals, NJ,
USA) and axial

-weighted images (i.e. post Gd-DTPA images) were acquired

with the same parameters as before.
Each piglet was administered 1.5 mL/kg of EB (Sigma-Aldrich, MO, USA)
approximately 2.5 hours after sonication. The piglet was euthanized 1 hour after
the injection, and the brain harvested and fixed in formalin for at least 48 hours.
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2.2.3

Optimization of the FUS Power
Experiments were conducted at three FUS power groups categorized as

low power (1.5 W), medium power (2.5-3 W) and high power (6.0 W) (0.7, 0.97,
1.53 MPa, respectively) to determine the power setting sufficient to open the BBB
without causing hemorrhage. Increased BBB permeability was assessed by
acquiring

-weighted images following Gd-DTPA injection and by histological

staining with EB dye. Evidence of hemorrhage was assessed by EB staining and
by

-weighted imaging. All experimental and imaging details were the same as

outlined in section 2.2.2.

2.3 Data Analysis
The change in signal intensity caused by the leakage of Gd-DTPA was
determined by drawing a region of interest (ROI) around the 12 sonication
locations on the post Gd-DTPA

images. For comparison, the ROI was

superimposed on the contralateral side of the image to determine the signal
intensity in a non-sonicated region. Individual intensities in each ROI were
extracted using an in-house Matlab code (Mathworks, MA, USA). The ROIs of
the sonicated regions were guided by the original left/right, anterior/posterior and
head/ foot positioning of the 12 target locations that were obtained off the MRI
scanner for each piglet. A ratio between the sonicated ROI intensity to nonsonicated ROI intensity was taken for each piglet.
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The

value at a given power was calculated by fitting a single

exponential function to the multi-echo data:
(2.1)

[ ]

where

is the signal in the sonicated region at a given echo time,

at TE = 0, and

is the signal

.

Raw EPI FEAST and DW-ASL images were co-registered to the

-

weighted images using SPM software (Statistical Parametric Mapping, London,
UK). In Matlab, the registered EPI images were pair-wise subtracted and time
averaged to generate mean ASL (

) images for each b value in the FEAST and

DW-ASL data sets. ROI analysis was used to determine the ratios
and

⁄

⁄

from the FEAST and DW-ASL, respectively, for whole brain and

for the sonicated and the non-sonicated regions defined in the

-weighted

images. These ratios were used to calculate estimates of the arterial transit time
(

and the water exchange rate constant (

from Eq. 1.6 using an assumed blood

) in each ROI.

was calculated

of 1.49 s (47) and accounting for a time

delay of 0.065 s between the acquisitions of successive slices. kw was
determined by comparing the measured capillary fraction, A1, to a table of values
generated from Eq. 1.18 and Eq. 1.19 over a range of
min-1) using the calculated
brain tissue (1.26 s).

value and assumed

values (0.01 to 500

values of blood (1.49 s) and
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2.4 Statistics and Sensitivity Analysis
Paired sample t-tests were used to compare measurements from the
sonicated and non-sonicated ROIs. Comparisons were conducted for signal
intensities in the contrast-enhanced
values from the DW-ASL data.

images, the

⁄

ratio and

Differences with p < 0.05 were considered

significant.
The signal-to-noise ratios (SNRs) of the FEAST and DW-ASL sequences
were characterized by measuring the temporal standard deviation in the
series. The SNR in each pixel was first calculated as the ratio of the mean signal,
Mp, to the corresponding standard deviation, σMp. The final image SNR was
defined as the average value across all pixels in the whole brain ROI.
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Chapter 3

3

Results

3.1 Optimization of the FUS Power
Data were acquired from a total of 11 animals: 2 in the low-power group
(1.5 W), 6 piglets in the medium-power group (5 at 2.5 W and 1 at 3 W) and 3 in
the high-power group (6 W). All animals were maintained at normal PaCO2
between 37 to 42 mmHg (40.63 ± 3.54 mmHg), and normal PaO2: 70 to 90
mmHg during sonication (79.42 ± 7.90 mmHg) and above 100 mmHg during
ASL. Mean heart rate was 144.33 ± 24.30 and blood glucose was always kept
above 4 mmol/l.
Figure 3.1 shows selected slices of post Gd-DTPA
and

-weighted images

-weighted images. Evidence of disruptions to the BBB is visible in the post

Gd-DTPA images, as seen from the enhanced intensity in the target area of
sonication (marked by the yellow arrows). Blood-brain barrier permeability
increased with sonication power as shown in Figure 3.2. This graph presents the
average signal ratio at the three powers for the sonicated ROI to the nonsonicated ROI from the post Gd-DTPA

-weighted images. A significant

increase in signal intensity in the sonicated ROI compared to the non-sonicated
ROI was found at the medium and high power levels.
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Figure 3.1:
Gd-DTPA

and

-weighted images at the three sonication powers. Row 1: Post

images, Row 2:

-weighted images. The yellow arrows indicate the

BBB opening while the orange arrows indicate the hemorrhage at the ventricles

.

Figure 3.2: Ratio of the signal intensity from the post Gd-DTPA T1-weighted
images from the sonicated ROI to the non-sonicated ROI plotted against the FUS
power. Asterisks indicate significant signal increase between the two ROIs.
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The post Gd-DTPA image enhancement caused by BBBD was evident by
EB staining as shown in Figure 3.3. Although qualitative, there was minimal
evidence of leakage at the lowest power; whereas, EB staining was observable
at the medium and high power groups.

Figure 3.3: Histology with Evans Blue dye seen on tissue sections that
corresponded to the targeted FUS slices.

Although Figure 3.2 illustrates that the greatest increase in BBB
permeability was observed at an FUS power of 6 W, the problem with using too
high of a power setting is the possibility of causing hemorrhaging, which could
affect the signal intensity in the ASL images through a change in the tissue
Evidence of hemorrohaging was observed in the

.

-weighted images displayed

in the second row of Figure 3.1. While only one set of

-weighted images were

collected at 6 W, hemorrhaging resulted in a lower signal intensity observed in
the sonicated ROI and a signal void around the ventricle near the ROI (dark
region in Figure 3.1 highlighted by the orange arrow). In contrast,

-weighted

images collected for all animals in the low and medium power groups were
uniform and showed no evidence of ventricular bleeding.

Figure 3.3: Histology with Evans Blue dye seen on tissue sections that
corresponded to the targeted FUS slices.
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Potential signal changes caused by bleeding were investigated by
measuring

in the sonicated and non-sonicated ROIs. Figure 3.4 displays the

signal intensity from the

-weighted images in the sonicated ROI at 6 W and in

both ROIs at the medium power. The similarity in signal decay between the
sonicated and non-sonicated ROIs for the medium power group suggests this
power level wasn’t sufficient to cause hemorrhaging. This was confirmed by the
average

values given in table 3.1, which showed no significant difference

between sonicated and non-sonicated ROIs at the low and medium power. In
contrast, the noticeably faster decay in the sonicated ROI at 6.0 W likely reflects
a decrease in tissue
lower

due to the leakage of red blood cells. For this animal, a

value was measured in the sonicated ROI compared to non-sonicated

side (Table 3.1).

Figure 3.4: Signal decay curves from the

-weighted images at 2.5 W (sonicated

and non-sonicated ROIs) and 6 W (sonicated ROI). The 2.5-W data were averaged
over 6 animals; whereas, the 6.0-W data were acquired from one animal.
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Table 3.1:

values of the sonicated and non-sonicated regions for all power

groups

Sonicated Region

Non-Sonicated Region (ms)

(ms)
Low-Power

46.10 ± 5.52

55.94 ± 13.33

Medium-Power

59.52 ± 10.01

50.00 ± 7.67

39.84

51.28

High-Power

3.2 DW-ASL Results
Table 3.2:

values of the sonicated and non-sonicated regions for all power

groupsA total of 5 piglets from the medium-power group were used in the FEAST

analysis, as FEAST data
were notRegion
collected on one
piglet. However,
data
from all
Sonicated
Non-Sonicated
Region
(ms)
6 animals were used in the (ms)
DW-ASL analysis. Figure 3.5 illustrates one set of a
post Gd-DTPA T1-weighted image and the corresponding coregistered b = 50
Low-Power
46.10 ± 5.52
55.94 ± 13.33
s/mm2 DW-ASL image.
Medium-Power
Average

59.52 ± 10.01
and

50.00 ± 7.67
ratios across the whole brain were

High-Power
39.84 respectively. Individual whole-brain
51.28
0.53
± 0.13 and 0.53 ± 0.08,
values from every piglet are presented in Table 3.2. The average
brain was 1.06 ± 0.12 s and the average whole-brain

and

for the whole

was 106 ± 15 min-1.
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Figure 3.5: a) Sonicated ROI as shown on the post Gd-DTPA

-weighted

image. b) Corresponding co-registered b = 50 s/mm2 DW-ASL image. c) The
fusion of the DW-ASL and the

-weighted images to demonstrate the overlap.

The coregistration image is produced using MRIcron (Neuroimaging Tools and
Resources, McCausland Center for Brain Imaging, SC, USA).

Table 3.3: Whole-brain average tissue transit time ( ) and water exchange rate (

Piglet

(s)

(min-1)

1

1.09

97

2

0.93

118

3

0.95

100

4

1.11

129

5

1.23

106

6

-

86

Mean

1.06 ± 0.12

106 ± 15.43

Figure 3.5: a) Sonicated ROI as shown on the post Gd-DTPA

-weighted image.

b) Corresponding co-registered b = 50 s/mm2 DW-ASL image. c) The fusion of
the DW-ASL and the

-weighted images to demonstrate the overlap. The

coregistration image is produced using MRIcron (Neuroimaging Tools and
Resources, McCausland Center for Brain Imaging, SC, USA).

)

50

FEAST and DW-ASL images from one piglet are shown in Figure 3.6.
These images have been masked to isolate the brain and were smoothed with a
7-mm Gaussian kernel for visualization. Each set of images includes the
image in the first row, the
/

image in the second row, and the ratio image of

in the third row. For this example, whole-brain ∆

and

were 0.66 and 0.64, respectively.

Individual

values and the corresponding

piglets are provided in Table 3.3. These

values for all

estimates were derived using

individual b values, except for piglet 6 for whom it was necessary to use the
group average value. There were no statistically significant differences between
the

values for the sonicated and non-sonicated regions. Similarly

there was no significant difference in the

values between the two sides.

The mean pixel SNR measurements from the FEAST and DW-ASL data
sets are shown in Table 3.4. As expected, the SNR for the FEAST data were
higher than for the DW-ASL data because the former were acquired with a
shorter PLD and a smaller b-value.
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Figure 3.6: FEAST and DW-ASL data from one piglet: (a) FEAST data acquired
with a PLD = 500 ms and (b) DW-ASL data acquired with a PLD = 1000 ms.
Each data set shows the average diffusion-weighted
in the second row. The ratio image,

/

in the first row and
is shown in the third

row. The b values for FEAST and DW-ASL were 10 and 50 s/mm2, respectively.
All images have been first masked to show only the brain and smoothed with a
7-mm Gaussian filter.

52

Table 3.5: Calculated water exchange rate (

) for the sonicated and non-sonicated regions

for all 6 piglets.
Sonicated

Non Sonicated
(min-1)

Piglet

(min-1)

1

0.51

99

0.47

88

2

0.46

65

0.52

77

3

0.52

81

0.50

77

4

0.58

136

0.54

116

5

0.52

125

0.50

119

6

0.41

77

0.53

120

Mean

0.50 ± 0.06

97.17 ± 28.25

0.51± 0.02

99.50 ± 21.06

Table 3.7: Mean pixel SNR in the FEAST and DW-ASL image sets.

Image Series
Table 3.6: Calculated water exchange rate (
for all 6 piglets.

SNR
) for the sonicated and non-sonicated regions

1.63 ± 0.41

FEAST

0.83 ± 0.41
Non Sonicated

FEAST
Sonicated
Piglet

DW-ASL

(min-1)

(min-1)

0.61 ± 0.15

DW-ASL
1

1.07 ± 0.22

0.51

99

0.47

88

Values
were averaged
across five piglets
for FEAST and
six piglets for DW-ASL.
2
0.46
65
0.52
77
3

0.52

81

0.50

77

4

0.58

136

0.54

116

5

0.52

125

0.50

119

53

Chapter 4

4

Discussion
The goal of this project was to assess if an ASL sequence designed to

measure the rate of water exchange across the BBB would be sensitive to
increases in BBB permeability (46). Focused ultrasound in combination with
microbubbles was used to open the BBB in newborn piglets. As FUS has not
been previously applied to this animal model, the first step was to optimize the
FUS parameters using contrast-enhanced

-weighted MRI and Evans Blue dye

to evaluate changes in permeability. Significant BBB opening was visualized in
post Gd-DTPA

-weighted images for sonication powers greater than or equal to

2.5 W (0.97 MPa), as determined by comparing signal enhancement in the predefined sonicated region to a non-sonicated control region in the contralateral
hemisphere. These results were also affirmed by the qualitative observations of
EB dye leakage into the targetted region. At the highest power setting (6.0 W),
there was evidence in the

-weighted images and the EB dye staining of

intracerebral hemorrhaging, particularly near the ventricles. The sensitivity to
bleeding is likely greater in this region because of an enhancement of the
cavitational effect due to the difference in acoustic impedance between CSF and
brain tissue (84).
There have been a few studies performing FUS on swine; however, these
studies involved larger pigs, which required either a craniotomy or thinning of the
skull to achieve a successful BBB disruption (84–86). Because of this, lower
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overall peak negative pressures and shorter sonication times were required
compared to the values used in this thesis. For example, Wei et al., observed an
increase and EB dye enhancement in adult pigs with craniotomies at a FUS
pressure of 0.43 MPa and hemorrhage at 0.56 MPa (85). Similarly, Liu et al.,
reported BBB disruption in pigs (5-8 kg) with thinned craniums at peak negative
pressures of 0.52 and 0.78 MPa (86). Because the skull is substantially thinner in
newborn piglets (approximately 1 to 2 mm in thickness), it was possible to
sonicate through the intact head in the current study. However, the distortion
caused by the skull, which we attempted to minimize by positioning the head
normal to the ultrasound beam, would explain the higher power requirements.
Previous studies have estimated that the beam distortion due to the skull can
cause 30% to 50% loss in pressure (84,85). The power setting used in the
current study was also greater than the value used in a rabbit model with the
same FUS system. With rabbits, a power of 0.5 W for a sonication time of 120 s
was sufficient to open the BBB, while power levels greater than 0.55 W resulted
in hemorrhage (87).
In contrast to the Gd-DTPA

-weighted data, the

⁄

ratio

derived from the DW-ASL images showed no significant difference between the
sonicated and non-sonicated ROIs. In fact, the difference between the mean
values from the two ROIs was only 2% (Table 3.3). It was anticipated that the
⁄

ratio would be greater in the sonicated region since an increase in

BBB permeability would be expected to increase

, resulting in a greater

fraction of labeled water diffusing the tissue compartment.
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There are a number of reasons that could explain the apparent
insensitivity of the DW-ASL technique to changes in BBB permeability. First,
water exchange across the BBB could already be very fast and therefore opening
the barrier would only cause a small increase in the amount of labeled water in
the tissue compartment. To understand this relationship, the predicted capillary
fraction of labeled water, A1, is plotted as function of

in figure 4.1. This graph

illustrates the non-linear relationship between A1 and

and, more importantly, it

demonstrates the small variation in A1 at higher

values. For example,

increasing

from 150 to 250 min-1 would only result in approximately a 25%

change in A1.

Figure 4.1: Predicted capillary fraction of labeled water (A1) plotted as a function of
the water-exchange rate (

. These simulated data were generated using T1b = 1.26

s, T1a = 1.49 s, a labeling duration of 1.5 s,

= 1.06 s and a PLD of 1.0 s.
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Higher
reported
correspond to

values could be expected considering that some studies have
values greater than 300 ml/100 g/min (88,89), which would
values around 200 min-1 since the capillary blood volume is

approximately 1.5 ml/100 g (90). However, there is considerable variation in
estimates between studies, with values in the range of 120 to 150 mL/100 g/min
reported for humans (88), monkeys (91) and rabbits (92). These estimates are in
the range expected if

was closer to 100 min-1, as measured in the current
⁄

study. Furthermore, the predicted

ratio for higher

values would be

much greater than the values measured in this study. The average value was
0.53 ± 0.08, which indicates that only half of the labeled water diffused into the
tissue.
A second possible reason why the DW-ASL sequence was unable to
detect an increase in BBB permeability could be due to its inherently poor SNR.
As shown in Table 3.4, the temporal SNR in a pixel was only around 1 in the DWASL images before applying the diffusion gradient and was reduced to 0.64 for b
= 50 s/mm2. The SNR limitations of ASL and the challenges it present for
measuring

are known (41,47) and in the current study the number of

repetitions, particularly for b = 50 s/mm2, was chosen to overcome this limitation.
Based on the number of repetitions acquired, the size of the sonicated ROI, and
the pixel noise calculations, a change of 11 to 15% in

⁄

should have

been detectable in the current experiments. This prediction was confirmed by the
reproducibility of the measured

⁄

ratios given in Table 3.3. Based on
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these data, a difference of 10.5% between the sonicated and non-sonicated
regions would be significant for a sample size of 6.
A third possible reason that the DW-ASL sequence did not detect an
increased in water exchange across the BBB may be that the applied diffusion
gradient did not sufficiently suppress the signal from the labeled water in the
capillary compartment. The strength of the diffusion gradient was selected based
on the average speed of blood in capillaries (35). Although it was only applied in
the one direction (slice encoding), the assumption is that the tortuosity of cerebral
vessels is sufficient, such that vascular spins undergo pseudo random motion as
they move through the capillaries. The adequacy of the selected diffusion
gradient strength and any directional dependency could be explored by repeating
the experiment across a range of b values and by applying diffusion gradients in
all three directions. However, this would be extremely challenging with the
current experiment considering the large number of repetitions required to detect
changes in a focal spot caused by FUS sonication and the finite window that the
BBB remains open (83). Since each targeted location requires a separate
injection of microbubbles and a two-minute period of sonication, the total duration
could quickly become prohibitively long. Future experiments could be conducted
at higher field strengths to improve the SNR and with an animal species, such as
the rat, in which whole-brain changes in permeability have been successively
conducted using carotid infusion of mannitol (21,93,94).
Other parameters measured in this study include the tissue transit time
( ). Since

values are affected by transit times and signal contributions from
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arterial blood,

was measured using the FEAST approach with a PLD chosen

that is greater than the arterial transit time. The PLD of 1 s applied during the
DW-ASL sequence was slightly shorter than the measured

of 1.06 s, indicating

that not all of the labeled water reached the brain tissue. However, the
⁄
⁄

ratio of 0.53 ± 0.13 calculated in this study was similar to the
value of 0.57 recorded in the previous study on humans (47).
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5

Summary

5.1 Limitations and Future Work
The BBB in a piglet model was successfully opened by FUS as
demonstrated

by

both

contrast-enhanced

MRI

and

Evans

blue

dye.

Unfortunately, although the water exchange rate measured in this study was in
good agreement to previous studies and had good reproducibility, the study
failed to find any detectable increases in water permeability in the sonicated
regions by DW-ASL. However, DW-ASL is only one approach for measuring
water exchange across the BBB by MRI. Alternative techniques include the use
of vascular contrast agents to alter the blood relaxation times, either the

or the

(44,95,96). A recent study conducted by Huang et al., reported a significant
increase in their measured water exchange index (WEI) after a bolus injection of
mannitol (95,96). Another ASL-based technique is to use differences in the
relaxation times (

and

) between blood and tissue, rather than diffusion

gradients, to distinguish the fractions of labeled water in the two compartments.
The sensitivity of this approach was recently improved by the development of a
3D gradient and spin echo PASL technique with a multi-echo readout (44,97).
This method focused on

imaging because of the greater difference between

values in blood and tissue compared to

differences. The increase in SNR by

3D imaging helps compensate for the subtle signal changes caused by relaxation
differences (43,97). However, the greater sensitivity of this approach compared
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to DW-ASL has not been tested. The advantage of a non-contrast-based method
is it could be easily incorporated into on-going clinical studies, such as
investigating changes in the BBB integrity associated with dementia. Newer
techniques

such

as

the

above

will

improve

the

understanding

of

pathophysiological mechanisms of BBB associated with AD progression and
would also assist in the discovery of new therapeutic treatment methods.

5.2 Conclusion
In conclusion, the water exchange rate is a challenging parameter to
measure, in particular due to the extremely controlled nature of water transport
across the BBB. This study demonstrated the ability to successfully open the
BBB in a piglet model to create a BBB-compromised environment. The

and

measurements were in good agreement with the previous studies, but lacked
sensitivity to discern permeability changes between the sonicated and nonsonicated regions.
ASL still remains a non-invasive, safe and a quantitative technique for
measuring perfusion, but further work is required to develop a method that is
sensitive to water exchange.
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